Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes

NCT01416649 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT01416649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01416649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Completed
Start date
February 1, 2011
Completion date
April 21, 2021
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes